Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats

Breast Cancer Research and Treatment

Volumn 45, Issue 2, 1997, Pages 159-167

  Page, Gayle Giboney ^a   Ben Eliyahu, Shamgar ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer; Estrous cycle; Metastasis; Natural killer cell; Rat; Surgery

Indexed keywords

HALOTHANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ESTRUS; ESTRUS CYCLE; FEMALE; HOST RESISTANCE; LAPAROTOMY; MALE; MENSTRUAL CYCLE; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PREMENOPAUSE; PRIORITY JOURNAL; PROESTRUS; RAT; SEX DIFFERENCE; TREATMENT PLANNING;

ADENOCARCINOMA; ANESTHESIA; ANIMALS; ESTRUS; FEMALE; KILLER CELLS, NATURAL; LAPAROTOMY; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, ANIMAL; RATS; RATS, INBRED F344; SEX FACTORS;

EID: 0030755148     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005826403235     Document Type: Article

References (55)

1. Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Dubens RD, Fentiman IS: Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 33: 1261-1264, 1991
2. Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD: Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 30A: 445-448, 1994
3. Hrushesky WJM, Bluming AZ, Gruber SA, Sothern RB: Menstrual influence on surgical cure of breast cancer. Lancet ii: 949-952, 1989
4. Kurebayashi J, Sonoo H, Shimozuma K: Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer. Jpn J Surg 25: 519-524, 1995
5. Saad Z, Bramwell V, Duff J, Girotti M, Jory T, Heathcote G, Turnbull I, Garcia B, Stitt L: Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer. Br J Surg 81: 217-220, 1994
6. Sainsbury R, Jones M, Parker D, Hall R, Close H: Timing of surgery for breast cancer and menstrual cycle (letter). Lancet 338: 392, 1991
7. Senie RT, Rosen PP, Rhodes P, Lesser ML: Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Int Med 115: 337-342, 1991
8. Spratt JS, Zirnheld J, Yancey JM: Breast Cancer Detection Demonstration Project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle. J Surg Oncol 53: 4-9, 1993
9. Veronesi U, Luini A, Mariani L, Del Vecchio M, Alvez D, Andreoli C, Giacobone A, Merson M, Pacetti G, Raselli R, Saccozzi R: Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343: 1544-1546, 1994
10. Donegan WL, Shah D: Prognosis of patients with breast cancer related to the timing of operation. Arch Surg 128: 309-313, 1993
11. Gnant MFX, Seifert M, Jakesz R, Adler A, Mittlboeck M, Sevelda P: Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women. Int J Cancer 52: 707-712, 1992
12. Jäger W, Sauerbrei W: Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients. Br Cancer Res Treat 34: 279-287, 1995
13. Kroman N, Højgaard A, Anderson K, Graversen HP, Afzelius P, Lokdam A, Juul C, Hoffman J, Bentzon N, Mouridsen HT: Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Eur J Surg Oncol 20: 430-435, 1994
14. Nathan B, Bates T, Anbazhagan R, Norman AR: Timing of surgery for breast cancer in relation to the menstrual cycle and survival of premenopausal women. Br J Surg 80: 43, 1993
15. Powles TJ, Jones AL, Ashley S, Tidy A: Menstrual effect on surgical cure of breast cancer (letter). Lancet 2: 1343-1344, 1989
16. Ben-Eliyahu S, Page GG, Shakhar G, Taylor AN: Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: Possible role of oestradiol and natural killer cells. Br J Cancer 74: 1900-1907, 1996
17. Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW: Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134: 2783-2789, 1985
18. Ben-Eliyahu S, Page GO: The in vivo assessment of natural killer cell activity in rats. Prog Neuroendocrinimmunol 5: 199-214, 1992
19. Van den Brink MRM, Hunt LE, Hiserodt JC: In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 171: 197-210, 1990
20. Gruber SA, Hoffman RA, Sothern RB, Lakatua D, Carlson A, Simmons RL, Hrushesky WJM: Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery 104: 398-403, 1988
21. Hrushesky WJM, Gruber SAS, Sothern RB, Hoffman RA, Lakatua D, Carlson A, Cerra F, Simmons RL: Natural killer cell activity: Age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Nat Cancer Inst 80: 1232-1237, 1988
22. Sulke AN, Jones DB, Wood PJ: Variation in natural killer activity in peripheral blood during the menstrual cycle. Br Med J 290: 884-886, 1985
23. White D, Jones DB, Cooke T, Kirkham N: Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. Br J Cancer 46: 611-616, 1982
24. Page GG, Ben-Eliyahu S, Liebeskind JC: The role of LGL/MK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun 8: 241-250, 1994
25. Pollock RE, Babcock GF, Romsdahl MM, Nishioka K: Surgical stress-mediated suppression of murine natural killer cell cytotoxicity. Cancer Res 44: 3888-3891, 1984
26. Togo T, Hirai T, Takiyama W, Hattori T: Effects of surgical stress on natural killer activity, proliferative response of spleen cells and cytostatic activity of lung macrophages in rats. Gann 72: 790-794, 1981
27. McCulloch PG, MacIntyre A: Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg 80: 1005-1007, 1993
28. Pollock RE, Lotzová E. Stanford SD: Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch Surg 126: 338-342, 1991
29. Pollock RE, Lotzová E, Stanford SD: Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer 70:2192-2202, 1992
30. Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC: Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54: 21-28, 1993
31. Hattori T, Hamai Y, Harada T, Ikeda H, Ikeda T: Enhancing effect of thoracotomy and/or laparotomy on the development of the lung metastases in rats after intravenous inoculation of tumor cells. Jap J Surg 7: 263-268, 1977
32. 125I-Iodo-2′-deoxyuridine. J Nat Cancer Inst 45: 773-782, 1970
33. Everett JW: Neurobiology of Reproduction in the Female Rat. Springer-Verlag, Berlin, 1989, pp 133
34. Tønnesen E, Brinkløv MM, Christensen NJ, Olesen AS, Madsen T: Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response. Anesthesiology 67: 526-533, 1987
35. Lundy J, Lovett EJ, Hamilton S, Conran P: Halothane, surgery, immunosuppression and artificial pulmonary metastases. Cancer 41: 827-830, 1978
36. Takekoshi T, Sakata K, Kunieda T, Saji S, Tanemura H, Yamamoto S: Facilitation of tumor metastasis by operative stress and participation of cell-mediated immunity. Oncology 41: 245-251, 1984
37. Tanemura H, Sakata K, Kunieda T, Saji S, Yamamoto S, Takekoshi T: Influences of operative stress on cell-mediated immunity and on tumor metastasis and their prevention by nonspecific immunotherapy: Experimental studies in rats. J Surg Oncol 21: 189-195, 1982
38. Thyss A, Caldani C, Bourcier C, Benita G, Schneider M: Comparison of natural killer activity during the first and second halves of the menstrual cycle in women (letter). Br J Cancer 50: 127-128, 1984
39. Pross HF, Lotzová E: Role of natural killer cells in cancer. Nat Immun 12: 279-292, 1993
40. Trinchieri G: Biology of natural killer cells. Adv Immunol 47: 187-376, 1989
41. Levy SM, Herberman RB, Maluish AM, Schlien B, Lippman M: Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 4: 99-113, 1985
42. Schantz SP, Brown BW, Lira E, Taylor DL, Beddingfield N: Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25: 141-145, 1987
43. Tartter PI, Steinberg B, Barron DM, Martinelli G: The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 122: 1264-1268, 1987
44. Benner BG, Margolese RG: The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer 68: 482-488, 1991
45. Zielinski CC, Tichatschek E, Muller C, Kalinowski W, Sevelda P, Czerwenka D, Kubista E, Spona J: Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer. Cancer 63: 1985-1989, 1989
46. Uchida A, Kolb R, Micksche M: Generation of suppressor cells for natural killer activity in cancer patients after surgery. J Nat Cancer Inst 68: 735-741, 1982
47. Sachs G, Rasoul-Rockenschaub S, Aschauer H, Spiess K, Gober I, Staffen A, Zielinski C: Lytic effector cell activity and major depressive disorder in patients with breast cancer: A prospective study. J Neuroimmunol 1-2: 83-89, 1995
48. Konjevic G, Spuzic I: Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma 40: 81-85, 1993
49. Garzetto GG, Civattini A, Goteri G, Tranquilli AL, Muzzioli M, Fabris N, De Nictolis M, Romanini C: Natural killer cell activity in Stage I endometrial carcinoma: Correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen. Gynecol Oncol 55: 111-114, 1994
50. Park SK, Brody JI, Wallace HA, Blakemore WS: Immunosuppressive effect of surgery. Lancet 7688: 53-55, 1971
51. Tønnesen E: Immunological aspects of anaesthesia and surgery - with special reference to NK cells. Dan Med Bull 36: 263-281, 1989
52. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 30: 107-112, 1982
53. Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Nat Cancer Inst 65: 801-809, 1980
54. Wiltrout RH, Herberman RB, Zhang S, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE: Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134: 4267-4275, 1985
55. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP: Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behav Immun 5: 193-205, 1991